secwatch / observer
8-K filed April 4, 2022, 7:59 PM ET ticker NUTX CIK 0001479681
M&A confidence high sentiment neutral materiality 1.00

Nutex Health completes reverse merger with Clinigence; issues 592.8M shares, new board and name

Nutex Health Inc.

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Mitchell Creem

Director
NUTX · Nutex Health Inc.
Effective
2022-04-01
Filed
April 4, 2022, 7:59 PM ET
the Company’s stockholders elected the individuals listed below to serve as directors of the Company: • Thomas T. Vo, M.D.; Warren Hosseinion, M.D.; Matthew S. Young, M.D.; John Waters, CPA; Cheryl Grenas, R.N., M.S.N.; Michael L. Reed, and Mitchell Creem
Departed

Brandon Sim

Director
NUTX · Nutex Health Inc.
Effective
2022-04-01
Filed
April 4, 2022, 7:59 PM ET
each of Terence Martin Breslin, Mark Fawcett, Jacob Margolin, David Meiri, Fred Sternberg, Robert Chan and Brandon Sim resigned from the board of directors of the Company.
Appointed

Michael L. Reed

Director
NUTX · Nutex Health Inc.
Effective
2022-04-01
Filed
April 4, 2022, 7:59 PM ET
the Company’s stockholders elected the individuals listed below to serve as directors of the Company: • Thomas T. Vo, M.D.; Warren Hosseinion, M.D.; Matthew S. Young, M.D.; John Waters, CPA; Cheryl Grenas, R.N., M.S.N.; Michael L. Reed, and Mitchell Creem
Appointed

Elisa Luqman

Chief Legal Officer (SEC)
NUTX · Nutex Health Inc.
Effective
2022-04-01
Filed
April 4, 2022, 7:59 PM ET
immediately following the Effective Time, the following became the officers of the Company: Name: Office Thomas T. Vo, M.D. Chief Executive Officer Warren Hosseinion, M.D. President Michael Bowen Chief Financial Officer Denise Pufal Chief Operating Officer Michael Chang, M.D. Chief Medical Officer Lawrence Schimmel, M.D. Chief Medical Information Officer Elisa Luqman, J.D./MBA Chief Legal Officer (SEC) Pamela Montgomery, R.N., J.D. Chief Legal Officer (Healthcare) & Secretary
Departed

David Meiri

Director
NUTX · Nutex Health Inc.
Effective
2022-04-01
Filed
April 4, 2022, 7:59 PM ET
each of Terence Martin Breslin, Mark Fawcett, Jacob Margolin, David Meiri, Fred Sternberg, Robert Chan and Brandon Sim resigned from the board of directors of the Company.
Departed

Robert Chan

Director
NUTX · Nutex Health Inc.
Effective
2022-04-01
Filed
April 4, 2022, 7:59 PM ET
each of Terence Martin Breslin, Mark Fawcett, Jacob Margolin, David Meiri, Fred Sternberg, Robert Chan and Brandon Sim resigned from the board of directors of the Company.
Appointed

Michael Bowen

Chief Financial Officer
NUTX · Nutex Health Inc.
Effective
2022-04-01
Filed
April 4, 2022, 7:59 PM ET
immediately following the Effective Time, the following became the officers of the Company: Name: Office Thomas T. Vo, M.D. Chief Executive Officer Warren Hosseinion, M.D. President Michael Bowen Chief Financial Officer Denise Pufal Chief Operating Officer Michael Chang, M.D. Chief Medical Officer Lawrence Schimmel, M.D. Chief Medical Information Officer Elisa Luqman, J.D./MBA Chief Legal Officer (SEC) Pamela Montgomery, R.N., J.D. Chief Legal Officer (Healthcare) & Secretary
Appointed

Thomas T. Vo

Director
NUTX · Nutex Health Inc.
Effective
2022-04-01
Filed
April 4, 2022, 7:59 PM ET
the Company’s stockholders elected the individuals listed below to serve as directors of the Company: • Thomas T. Vo, M.D.; Warren Hosseinion, M.D.; Matthew S. Young, M.D.; John Waters, CPA; Cheryl Grenas, R.N., M.S.N.; Michael L. Reed, and Mitchell Creem
Departed

Jacob Margolin

Director
NUTX · Nutex Health Inc.
Effective
2022-04-01
Filed
April 4, 2022, 7:59 PM ET
each of Terence Martin Breslin, Mark Fawcett, Jacob Margolin, David Meiri, Fred Sternberg, Robert Chan and Brandon Sim resigned from the board of directors of the Company.
Appointed

Thomas T. Vo

Chairman of the Board
NUTX · Nutex Health Inc.
Effective
2022-04-01
Filed
April 4, 2022, 7:59 PM ET
Thomas T. Vo, MD on April 1, 2022 was appointed as the Company’s Chief Executive Officer and elected, effective April 1, 2022, as the Chairman of the Board.
Appointed

Thomas T. Vo

Chief Executive Officer
NUTX · Nutex Health Inc.
Effective
2022-04-01
Filed
April 4, 2022, 7:59 PM ET
immediately following the Effective Time, the following became the officers of the Company: Name: Office Thomas T. Vo, M.D. Chief Executive Officer Warren Hosseinion, M.D. President Michael Bowen Chief Financial Officer Denise Pufal Chief Operating Officer Michael Chang, M.D. Chief Medical Officer Lawrence Schimmel, M.D. Chief Medical Information Officer Elisa Luqman, J.D./MBA Chief Legal Officer (SEC) Pamela Montgomery, R.N., J.D. Chief Legal Officer (Healthcare) & Secretary
Appointed

Michael Chang

Chief Medical Officer
NUTX · Nutex Health Inc.
Effective
2022-04-01
Filed
April 4, 2022, 7:59 PM ET
immediately following the Effective Time, the following became the officers of the Company: Name: Office Thomas T. Vo, M.D. Chief Executive Officer Warren Hosseinion, M.D. President Michael Bowen Chief Financial Officer Denise Pufal Chief Operating Officer Michael Chang, M.D. Chief Medical Officer Lawrence Schimmel, M.D. Chief Medical Information Officer Elisa Luqman, J.D./MBA Chief Legal Officer (SEC) Pamela Montgomery, R.N., J.D. Chief Legal Officer (Healthcare) & Secretary
Appointed

Pamela Montgomery

Chief Legal Officer (Healthcare) & Secretary
NUTX · Nutex Health Inc.
Effective
2022-04-01
Filed
April 4, 2022, 7:59 PM ET
immediately following the Effective Time, the following became the officers of the Company: Name: Office Thomas T. Vo, M.D. Chief Executive Officer Warren Hosseinion, M.D. President Michael Bowen Chief Financial Officer Denise Pufal Chief Operating Officer Michael Chang, M.D. Chief Medical Officer Lawrence Schimmel, M.D. Chief Medical Information Officer Elisa Luqman, J.D./MBA Chief Legal Officer (SEC) Pamela Montgomery, R.N., J.D. Chief Legal Officer (Healthcare) & Secretary
Appointed

John Waters

Director
NUTX · Nutex Health Inc.
Effective
2022-04-01
Filed
April 4, 2022, 7:59 PM ET
the Company’s stockholders elected the individuals listed below to serve as directors of the Company: • Thomas T. Vo, M.D.; Warren Hosseinion, M.D.; Matthew S. Young, M.D.; John Waters, CPA; Cheryl Grenas, R.N., M.S.N.; Michael L. Reed, and Mitchell Creem
Departed

Mark Fawcett

Director
NUTX · Nutex Health Inc.
Effective
2022-04-01
Filed
April 4, 2022, 7:59 PM ET
each of Terence Martin Breslin, Mark Fawcett, Jacob Margolin, David Meiri, Fred Sternberg, Robert Chan and Brandon Sim resigned from the board of directors of the Company.
Appointed

Denise Pufal

Chief Operating Officer
NUTX · Nutex Health Inc.
Effective
2022-04-01
Filed
April 4, 2022, 7:59 PM ET
immediately following the Effective Time, the following became the officers of the Company: Name: Office Thomas T. Vo, M.D. Chief Executive Officer Warren Hosseinion, M.D. President Michael Bowen Chief Financial Officer Denise Pufal Chief Operating Officer Michael Chang, M.D. Chief Medical Officer Lawrence Schimmel, M.D. Chief Medical Information Officer Elisa Luqman, J.D./MBA Chief Legal Officer (SEC) Pamela Montgomery, R.N., J.D. Chief Legal Officer (Healthcare) & Secretary
Departed

Terence Martin Breslin

Director
NUTX · Nutex Health Inc.
Effective
2022-04-01
Filed
April 4, 2022, 7:59 PM ET
each of Terence Martin Breslin, Mark Fawcett, Jacob Margolin, David Meiri, Fred Sternberg, Robert Chan and Brandon Sim resigned from the board of directors of the Company.
Appointed

Warren Hosseinion

President
NUTX · Nutex Health Inc.
Effective
2022-04-01
Filed
April 4, 2022, 7:59 PM ET
immediately following the Effective Time, the following became the officers of the Company: Name: Office Thomas T. Vo, M.D. Chief Executive Officer Warren Hosseinion, M.D. President Michael Bowen Chief Financial Officer Denise Pufal Chief Operating Officer Michael Chang, M.D. Chief Medical Officer Lawrence Schimmel, M.D. Chief Medical Information Officer Elisa Luqman, J.D./MBA Chief Legal Officer (SEC) Pamela Montgomery, R.N., J.D. Chief Legal Officer (Healthcare) & Secretary
Appointed

Warren Hosseinion

Director
NUTX · Nutex Health Inc.
Effective
2022-04-01
Filed
April 4, 2022, 7:59 PM ET
the Company’s stockholders elected the individuals listed below to serve as directors of the Company: • Thomas T. Vo, M.D.; Warren Hosseinion, M.D.; Matthew S. Young, M.D.; John Waters, CPA; Cheryl Grenas, R.N., M.S.N.; Michael L. Reed, and Mitchell Creem
Departed

Fred Sternberg

Director
NUTX · Nutex Health Inc.
Effective
2022-04-01
Filed
April 4, 2022, 7:59 PM ET
each of Terence Martin Breslin, Mark Fawcett, Jacob Margolin, David Meiri, Fred Sternberg, Robert Chan and Brandon Sim resigned from the board of directors of the Company.
Appointed

Lawrence Schimmel

Chief Medical Information Officer
NUTX · Nutex Health Inc.
Effective
2022-04-01
Filed
April 4, 2022, 7:59 PM ET
immediately following the Effective Time, the following became the officers of the Company: Name: Office Thomas T. Vo, M.D. Chief Executive Officer Warren Hosseinion, M.D. President Michael Bowen Chief Financial Officer Denise Pufal Chief Operating Officer Michael Chang, M.D. Chief Medical Officer Lawrence Schimmel, M.D. Chief Medical Information Officer Elisa Luqman, J.D./MBA Chief Legal Officer (SEC) Pamela Montgomery, R.N., J.D. Chief Legal Officer (Healthcare) & Secretary
Appointed

Cheryl Grenas

Director
NUTX · Nutex Health Inc.
Effective
2022-04-01
Filed
April 4, 2022, 7:59 PM ET
the Company’s stockholders elected the individuals listed below to serve as directors of the Company: • Thomas T. Vo, M.D.; Warren Hosseinion, M.D.; Matthew S. Young, M.D.; John Waters, CPA; Cheryl Grenas, R.N., M.S.N.; Michael L. Reed, and Mitchell Creem
Appointed

Matthew S. Young

Director
NUTX · Nutex Health Inc.
Effective
2022-04-01
Filed
April 4, 2022, 7:59 PM ET
the Company’s stockholders elected the individuals listed below to serve as directors of the Company: • Thomas T. Vo, M.D.; Warren Hosseinion, M.D.; Matthew S. Young, M.D.; John Waters, CPA; Cheryl Grenas, R.N., M.S.N.; Michael L. Reed, and Mitchell Creem

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Mitchell Creem was elected as Director at Nutex Health Inc..

Action
elected
Role
Director
Exact text from the filing
the Company’s stockholders elected the individuals listed below to serve as directors of the Company: • Thomas T. Vo, M.D.; Warren Hosseinion, M.D.; Matthew S. Young, M.D.; John Waters, CPA; Cheryl Grenas, R.N., M.S.N.; Michael L. Reed, and Mitchell Creem
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Brandon Sim resigned as Director at Nutex Health Inc..

Action
resigned
Role
Director
Exact text from the filing
each of Terence Martin Breslin, Mark Fawcett, Jacob Margolin, David Meiri, Fred Sternberg, Robert Chan and Brandon Sim resigned from the board of directors of the Company.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Michael L. Reed was elected as Director at Nutex Health Inc..

Action
elected
Role
Director
Exact text from the filing
the Company’s stockholders elected the individuals listed below to serve as directors of the Company: • Thomas T. Vo, M.D.; Warren Hosseinion, M.D.; Matthew S. Young, M.D.; John Waters, CPA; Cheryl Grenas, R.N., M.S.N.; Michael L. Reed, and Mitchell Creem
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Elisa Luqman was appointed as Chief Legal Officer (SEC) at Nutex Health Inc..

Action
appointed
Role
Chief Legal Officer (SEC)
Exact text from the filing
immediately following the Effective Time, the following became the officers of the Company: Name: Office Thomas T. Vo, M.D. Chief Executive Officer Warren Hosseinion, M.D. President Michael Bowen Chief Financial Officer Denise Pufal Chief Operating Officer Michael Chang, M.D. Chief Medical Officer Lawrence Schimmel, M.D. Chief Medical Information Officer Elisa Luqman, J.D./MBA Chief Legal Officer (SEC) Pamela Montgomery, R.N., J.D. Chief Legal Officer (Healthcare) & Secretary
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

David Meiri resigned as Director at Nutex Health Inc..

Action
resigned
Role
Director
Exact text from the filing
each of Terence Martin Breslin, Mark Fawcett, Jacob Margolin, David Meiri, Fred Sternberg, Robert Chan and Brandon Sim resigned from the board of directors of the Company.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Robert Chan resigned as Director at Nutex Health Inc..

Action
resigned
Role
Director
Exact text from the filing
each of Terence Martin Breslin, Mark Fawcett, Jacob Margolin, David Meiri, Fred Sternberg, Robert Chan and Brandon Sim resigned from the board of directors of the Company.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Michael Bowen was appointed as Chief Financial Officer at Nutex Health Inc..

Action
appointed
Role
Chief Financial Officer
Exact text from the filing
immediately following the Effective Time, the following became the officers of the Company: Name: Office Thomas T. Vo, M.D. Chief Executive Officer Warren Hosseinion, M.D. President Michael Bowen Chief Financial Officer Denise Pufal Chief Operating Officer Michael Chang, M.D. Chief Medical Officer Lawrence Schimmel, M.D. Chief Medical Information Officer Elisa Luqman, J.D./MBA Chief Legal Officer (SEC) Pamela Montgomery, R.N., J.D. Chief Legal Officer (Healthcare) & Secretary
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Thomas T. Vo was elected as Director at Nutex Health Inc..

Action
elected
Role
Director
Exact text from the filing
the Company’s stockholders elected the individuals listed below to serve as directors of the Company: • Thomas T. Vo, M.D.; Warren Hosseinion, M.D.; Matthew S. Young, M.D.; John Waters, CPA; Cheryl Grenas, R.N., M.S.N.; Michael L. Reed, and Mitchell Creem
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Jacob Margolin resigned as Director at Nutex Health Inc..

Action
resigned
Role
Director
Exact text from the filing
each of Terence Martin Breslin, Mark Fawcett, Jacob Margolin, David Meiri, Fred Sternberg, Robert Chan and Brandon Sim resigned from the board of directors of the Company.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Thomas T. Vo was elected as Chairman of the Board at Nutex Health Inc..

Action
elected
Role
Chairman of the Board
Exact text from the filing
Thomas T. Vo, MD on April 1, 2022 was appointed as the Company’s Chief Executive Officer and elected, effective April 1, 2022, as the Chairman of the Board.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Thomas T. Vo was appointed as Chief Executive Officer at Nutex Health Inc..

Action
appointed
Role
Chief Executive Officer
Exact text from the filing
immediately following the Effective Time, the following became the officers of the Company: Name: Office Thomas T. Vo, M.D. Chief Executive Officer Warren Hosseinion, M.D. President Michael Bowen Chief Financial Officer Denise Pufal Chief Operating Officer Michael Chang, M.D. Chief Medical Officer Lawrence Schimmel, M.D. Chief Medical Information Officer Elisa Luqman, J.D./MBA Chief Legal Officer (SEC) Pamela Montgomery, R.N., J.D. Chief Legal Officer (Healthcare) & Secretary
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Michael Chang was appointed as Chief Medical Officer at Nutex Health Inc..

Action
appointed
Role
Chief Medical Officer
Exact text from the filing
immediately following the Effective Time, the following became the officers of the Company: Name: Office Thomas T. Vo, M.D. Chief Executive Officer Warren Hosseinion, M.D. President Michael Bowen Chief Financial Officer Denise Pufal Chief Operating Officer Michael Chang, M.D. Chief Medical Officer Lawrence Schimmel, M.D. Chief Medical Information Officer Elisa Luqman, J.D./MBA Chief Legal Officer (SEC) Pamela Montgomery, R.N., J.D. Chief Legal Officer (Healthcare) & Secretary
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Pamela Montgomery was appointed as Chief Legal Officer (Healthcare) & Secretary at Nutex Health Inc..

Action
appointed
Role
Chief Legal Officer (Healthcare) & Secretary
Exact text from the filing
immediately following the Effective Time, the following became the officers of the Company: Name: Office Thomas T. Vo, M.D. Chief Executive Officer Warren Hosseinion, M.D. President Michael Bowen Chief Financial Officer Denise Pufal Chief Operating Officer Michael Chang, M.D. Chief Medical Officer Lawrence Schimmel, M.D. Chief Medical Information Officer Elisa Luqman, J.D./MBA Chief Legal Officer (SEC) Pamela Montgomery, R.N., J.D. Chief Legal Officer (Healthcare) & Secretary
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

John Waters was elected as Director at Nutex Health Inc..

Action
elected
Role
Director
Exact text from the filing
the Company’s stockholders elected the individuals listed below to serve as directors of the Company: • Thomas T. Vo, M.D.; Warren Hosseinion, M.D.; Matthew S. Young, M.D.; John Waters, CPA; Cheryl Grenas, R.N., M.S.N.; Michael L. Reed, and Mitchell Creem
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Mark Fawcett resigned as Director at Nutex Health Inc..

Action
resigned
Role
Director
Exact text from the filing
each of Terence Martin Breslin, Mark Fawcett, Jacob Margolin, David Meiri, Fred Sternberg, Robert Chan and Brandon Sim resigned from the board of directors of the Company.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Denise Pufal was appointed as Chief Operating Officer at Nutex Health Inc..

Action
appointed
Role
Chief Operating Officer
Exact text from the filing
immediately following the Effective Time, the following became the officers of the Company: Name: Office Thomas T. Vo, M.D. Chief Executive Officer Warren Hosseinion, M.D. President Michael Bowen Chief Financial Officer Denise Pufal Chief Operating Officer Michael Chang, M.D. Chief Medical Officer Lawrence Schimmel, M.D. Chief Medical Information Officer Elisa Luqman, J.D./MBA Chief Legal Officer (SEC) Pamela Montgomery, R.N., J.D. Chief Legal Officer (Healthcare) & Secretary
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Terence Martin Breslin resigned as Director at Nutex Health Inc..

Action
resigned
Role
Director
Exact text from the filing
each of Terence Martin Breslin, Mark Fawcett, Jacob Margolin, David Meiri, Fred Sternberg, Robert Chan and Brandon Sim resigned from the board of directors of the Company.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Warren Hosseinion was appointed as President at Nutex Health Inc..

Action
appointed
Role
President
Exact text from the filing
immediately following the Effective Time, the following became the officers of the Company: Name: Office Thomas T. Vo, M.D. Chief Executive Officer Warren Hosseinion, M.D. President Michael Bowen Chief Financial Officer Denise Pufal Chief Operating Officer Michael Chang, M.D. Chief Medical Officer Lawrence Schimmel, M.D. Chief Medical Information Officer Elisa Luqman, J.D./MBA Chief Legal Officer (SEC) Pamela Montgomery, R.N., J.D. Chief Legal Officer (Healthcare) & Secretary
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Warren Hosseinion was elected as Director at Nutex Health Inc..

Action
elected
Role
Director
Exact text from the filing
the Company’s stockholders elected the individuals listed below to serve as directors of the Company: • Thomas T. Vo, M.D.; Warren Hosseinion, M.D.; Matthew S. Young, M.D.; John Waters, CPA; Cheryl Grenas, R.N., M.S.N.; Michael L. Reed, and Mitchell Creem
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Fred Sternberg resigned as Director at Nutex Health Inc..

Action
resigned
Role
Director
Exact text from the filing
each of Terence Martin Breslin, Mark Fawcett, Jacob Margolin, David Meiri, Fred Sternberg, Robert Chan and Brandon Sim resigned from the board of directors of the Company.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Lawrence Schimmel was appointed as Chief Medical Information Officer at Nutex Health Inc..

Action
appointed
Role
Chief Medical Information Officer
Exact text from the filing
immediately following the Effective Time, the following became the officers of the Company: Name: Office Thomas T. Vo, M.D. Chief Executive Officer Warren Hosseinion, M.D. President Michael Bowen Chief Financial Officer Denise Pufal Chief Operating Officer Michael Chang, M.D. Chief Medical Officer Lawrence Schimmel, M.D. Chief Medical Information Officer Elisa Luqman, J.D./MBA Chief Legal Officer (SEC) Pamela Montgomery, R.N., J.D. Chief Legal Officer (Healthcare) & Secretary
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Cheryl Grenas was elected as Director at Nutex Health Inc..

Action
elected
Role
Director
Exact text from the filing
the Company’s stockholders elected the individuals listed below to serve as directors of the Company: • Thomas T. Vo, M.D.; Warren Hosseinion, M.D.; Matthew S. Young, M.D.; John Waters, CPA; Cheryl Grenas, R.N., M.S.N.; Michael L. Reed, and Mitchell Creem
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Matthew S. Young was elected as Director at Nutex Health Inc..

Action
elected
Role
Director
Exact text from the filing
the Company’s stockholders elected the individuals listed below to serve as directors of the Company: • Thomas T. Vo, M.D.; Warren Hosseinion, M.D.; Matthew S. Young, M.D.; John Waters, CPA; Cheryl Grenas, R.N., M.S.N.; Michael L. Reed, and Mitchell Creem
View on SEC.gov

Nutex Health Inc. filing history →

Source: SEC EDGAR
accession 0001607062-22-000244
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.